407 related articles for article (PubMed ID: 24096790)
1. A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.
Vancampfort D; Wampers M; Mitchell AJ; Correll CU; De Herdt A; Probst M; De Hert M
World Psychiatry; 2013 Oct; 12(3):240-50. PubMed ID: 24096790
[TBL] [Abstract][Full Text] [Related]
2. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
3. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
[TBL] [Abstract][Full Text] [Related]
4. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients.
Lang X; Zhou Y; Zhao L; Gu Y; Wu X; Zhao Y; Li Z; Zhang X
Psychoneuroendocrinology; 2021 Oct; 132():105344. PubMed ID: 34274733
[TBL] [Abstract][Full Text] [Related]
5. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors.
Correll CU; Solmi M; Croatto G; Schneider LK; Rohani-Montez SC; Fairley L; Smith N; Bitter I; Gorwood P; Taipale H; Tiihonen J
World Psychiatry; 2022 Jun; 21(2):248-271. PubMed ID: 35524619
[TBL] [Abstract][Full Text] [Related]
6. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls.
Wu X; Huang Z; Wu R; Zhong Z; Wei Q; Wang H; Diao F; Wang J; Zheng L; Zhao J; Zhang J
Schizophr Res; 2013 Oct; 150(1):157-62. PubMed ID: 23998954
[TBL] [Abstract][Full Text] [Related]
7. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls.
Tian Y; Wang D; Wei G; Wang J; Zhou H; Xu H; Dai Q; Xiu M; Chen D; Wang L; Zhang XY
Psychopharmacology (Berl); 2021 Mar; 238(3):745-753. PubMed ID: 33241480
[TBL] [Abstract][Full Text] [Related]
9. A Meta-Analysis of Abnormal Glucose Metabolism in First-Episode Drug-Naive Schizophrenia.
Yang W; Zheng L; Zheng B; Zeng S; Li J; Liang B; Zhu J; Zhang M
Psychiatr Danub; 2020; 32(1):46-54. PubMed ID: 32303029
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population.
Li Z; Wang S; Chen Y; Wu X; Gu Y; Lang X; Wu F; Zhang XY
Int J Neuropsychopharmacol; 2021 Oct; 24(10):798-807. PubMed ID: 34153098
[TBL] [Abstract][Full Text] [Related]
12. [Management of cardiovascular co-morbidities in young patients with early onset psychosis: State of the art and therapeutic perspectives].
Frajerman A; Morin V; Chaumette B; Kebir O; Krebs MO
Encephale; 2020 Oct; 46(5):390-398. PubMed ID: 32571543
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study.
De Hert M; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Clin Pract Epidemiol Ment Health; 2006 Jun; 2():14. PubMed ID: 16803620
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
[TBL] [Abstract][Full Text] [Related]
16. Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda.
Agaba DC; Migisha R; Katamba G; Ashaba S
PLoS One; 2020; 15(7):e0235956. PubMed ID: 32678850
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia.
Lang X; Liu Q; Fang H; Zhou Y; Forster MT; Li Z; Zhang X
Psychopharmacology (Berl); 2021 Dec; 238(12):3643-3652. PubMed ID: 34586464
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.
De Hert M; Schreurs V; Sweers K; Van Eyck D; Hanssens L; Sinko S; Wampers M; Scheen A; Peuskens J; van Winkel R
Schizophr Res; 2008 Apr; 101(1-3):295-303. PubMed ID: 18299188
[TBL] [Abstract][Full Text] [Related]
19. Impaired processing speed and attention in first-episode drug naive schizophrenia with deficit syndrome.
Chen C; Jiang W; Zhong N; Wu J; Jiang H; Du J; Li Y; Ma X; Zhao M; Hashimoto K; Gao C
Schizophr Res; 2014 Nov; 159(2-3):478-84. PubMed ID: 25261044
[TBL] [Abstract][Full Text] [Related]
20. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
